|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/137 | |
| A61K 31/4174 | |||
| A61K 8/30 | |||
| A61K 8/49 | |||
| A61Q 17/04 | |||
| A61Q 19/04 | |||
| A61P 35/00 |
| (11) | Number of the document | 2598129 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11738997.3 |
| Date of filing the European patent application | 2011-06-29 | |
| (97) | Date of publication of the European application | 2013-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/060939 |
| Date | 2011-06-29 |
| (87) | Number | WO 2012/001065 |
| Date | 2012-01-05 |
| (30) | Number | Date | Country code |
| 344333 P | 2010-06-30 | US |
| (72) |
BOUVIER, Guy, FR
LEONI, Matthew James, US
GRAEBER, Michael, US
|
| (73) |
Galderma Research & Development,
2400 Route des Colles Les Templiers, 06410 Biot,
FR
|
| (54) | USE OF ALPHA-ADRENERGIC RECEPTOR AGONIST FOR PREVENTING OR TREATING SKIN TUMOR |
| USE OF ALPHA-ADRENERGIC RECEPTOR AGONIST FOR PREVENTING OR TREATING SKIN TUMOR |